<?xml version="1.0" encoding="UTF-8"?>
<urlset
      xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
      xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
      xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9
            http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
<!-- created with Free Online Sitemap Generator www.xml-sitemaps.com -->

<url>
  <loc>http://www.gruppofirma.com/eng/</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/chi-siamo/soci</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/chi-siamo/soci-benemeriti</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/chi-siamo/gruppo-firma</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/404-error-page</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/linee-guida/anticorpi-anti-nucleo-in-immunofluorescenza-indiretta</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/linee-guida/anticorpi-anti-dna</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/linee-guida/autoanticorpi-anti-citoplasma-dei-neutrofili-anca</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/linee-guida/autoanticorpi-anti-fosfolipidi-revisione-gennaio-2007</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/privacy</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/linee-guida/autoanticorpi-anti-antigeni-nucleari-estraibili</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/linee-guida/</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/news/</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/download</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/progetti/approccio-del-laboratorio-analisi-alla-diagnostica-delle-malattie-autoimmuni-sistemiche-questionario</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/progetti/approccio-alla-diagnostica-autoimmune-in-particolare-per-la-ricerca-di-anticorpi-anti-nucleo-e-anticorpi-correlati-questionario</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/progetti/autoimmunity-diagnostic-strategies-ana-anti-dsdna-anti-ena-in-italian-clinical-laboratories</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/progetti/</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/progetti/proposta-di-collaborazione-scientifica-nell-ambito-della-diagnostica-in-vitro-delle-malattie-del-tessuto-connettivo</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/progetti/questinario-easi-anca</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/progetti/approach-to-laboratory-diagnostics-of-anca-associated-vasculitis-aav-in-italian-clinical-laboratories</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/progetti/approccio-alla-diagnostica-di-laboratorio-delle-vasculiti-anca-associate-vaa-nei-laboratori-clinici-italiani</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/progetti/questionario-firma-anca-surveymonkey</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/progetti/proposta-di-collaborazione-scientifica-nell-ambito-della-diasgnostica-in-vitro-delle-vasculiti-anca-associate</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/progetti/the-general-practice-guide-to-autoimmune-diseases</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/news/arthritis-research-therapy-22-gennaio-2013</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/news/clinical-and-experimental-rheumatology-2011</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/news/rheumatology-advance-access-6-dicembre-2010</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/news/autoimmunity-reviews-2012</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/news/clinical-and-experimental-rheumatology-2014</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/media/28/d-1/t-file/Anti-CCP-titer-predicts-time-to-RA-onset-in-patients-with-undifferentiated-arthritis_results-from-a-2-yr-prospective-study..pdf</loc>
  <lastmod>2016-03-25T09:59:56+00:00</lastmod>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/media/29/d-1/t-file/Anti-RoSSA-p200-antibodies-in-the-prediction-of-congenital-heart-block_An-Italian-multicentre-cross-sectional-study-onbehalf-of-the-FIRMA-group..pdf</loc>
  <lastmod>2016-03-25T09:59:56+00:00</lastmod>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/media/30/d-1/t-file/Detection-of-anti-IFI16-antibodies-by-ELISA-clinical-and-serological-associations-in-systemic-sclerosis..pdf</loc>
  <lastmod>2016-03-25T09:59:57+00:00</lastmod>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/media/31/d-1/t-file/Diagnostic-accuracy-of-currently-available-anti-dsDNA-antibody-assays_An-Italian-multicentre-study..pdf</loc>
  <lastmod>2016-03-25T09:59:57+00:00</lastmod>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/media/33/d-1/t-file/Diagnostic-value-of-anti-mutated-citrullinated-vimentin-in-comparison-to-anti-CCP-and-anti-viral-citrullinated-peptide-2-antibodies-in-RA_An-Italian-multicentric-study..pdf</loc>
  <lastmod>2016-03-25T09:59:57+00:00</lastmod>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/media/34/d-1/t-file/Evaluation-of-Current-Methods-for-the-Measurement-of-Serum-anti-dsDNA-antibodies..pdf</loc>
  <lastmod>2016-03-25T09:59:57+00:00</lastmod>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/media/35/d-1/t-file/From-ANA-screening-to-antigen-specificity_an-EASI-survey-on-the-daily-practice-in-European-countries..pdf</loc>
  <lastmod>2016-03-25T09:59:57+00:00</lastmod>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/media/36/d-1/t-file/International-recommendations-for-assessment-of-autoantibodies-to-cellular-antigens-referred-to-as-ANA..pdf</loc>
  <lastmod>2016-03-25T09:59:57+00:00</lastmod>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/media/37/d-1/t-file/Nuclear-DNA-sensor-IFI16-as-circulating-protein-in-autoimmune-diseases-is-a-signal-of-damage-that-impairs-endothelial-cells-through-high-affinity-membrane-binding..pdf</loc>
  <lastmod>2016-03-25T09:59:58+00:00</lastmod>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/media/38/d-1/t-file/Second-generation-analysis-of-antinuclear-antibody-ANA-by-combination-of-screening-and-confirmatory-testing..pdf</loc>
  <lastmod>2016-03-25T09:59:58+00:00</lastmod>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/media/39/d-1/t-file/Validation-of-a-new-immunoenzymatic-method-to-detect-antibodies-to-RNA-polymerase-III-in-systemic-sclerosis..pdf</loc>
  <lastmod>2016-03-25T09:59:59+00:00</lastmod>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/linee-guida/approccio-del-laboratorio-analisi-alla-diagnostica-delle-malattie-autoimmuni-sistemiche-questionario</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/linee-guida/approccio-alla-diagnostica-autoimmune-in-particolare-per-la-ricerca-di-anticorpi-anti-nucleo-e-anticorpi-correlati-questionario</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/linee-guida/autoimmunity-diagnostic-strategies-ana-anti-dsdna-anti-ena-in-italian-clinical-laboratories</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/linee-guida/proposta-di-collaborazione-scientifica-nell-ambito-della-diagnostica-in-vitro-delle-malattie-del-tessuto-connettivo</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/linee-guida/questinario-easi-anca</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/linee-guida/approach-to-laboratory-diagnostics-of-anca-associated-vasculitis-aav-in-italian-clinical-laboratories</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/linee-guida/approccio-alla-diagnostica-di-laboratorio-delle-vasculiti-anca-associate-vaa-nei-laboratori-clinici-italiani</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/linee-guida/questionario-firma-anca-surveymonkey</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/linee-guida/proposta-di-collaborazione-scientifica-nell-ambito-della-diasgnostica-in-vitro-delle-vasculiti-anca-associate</loc>
  <changefreq>weekly</changefreq>
</url>
<url>
  <loc>http://www.gruppofirma.com/ita/linee-guida/the-general-practice-guide-to-autoimmune-diseases</loc>
  <changefreq>weekly</changefreq>
</url>
</urlset>